TMTPOST--U.S. legislation that would restrict business with China's BGI, WuXi AppTec and certain other biotech companies on national security grounds will be voted on by a committee in the House of Representatives on Wednesday. If approved by the House Committee on Oversight and Accountability, the Biosecure Act would still need to be voted on by the full House and Senate before the president could sign it into law. The bill would push U.S. pharmaceutical and healthcare companies to lessen their reliance on Chinese research and manufacturing.